 |
|
|
| |
Advanced Mechanistic Studies of GSK1265744, a New HIV Integrase Inhibitor (INI) Dosed by Oral Administration or Long-Acting Parenteral Injection
|
| |
| |
Reported by Jules Levin
International Workshop on HIV & Hepatitis Virus Drug Resistance and Curative Strategies; June 4-8, 2013; Toronto, ON, Canada
T Yoshinaga,1 M Kobayashi,1 T Seki,1 C Wakasa-Morimoto,1 T Kawasuji,1 T Taishi,1 A Sato,1 T Fujiwara,1 B Johns,2 M Underwood2
1Shionogi & Co., Ltd., Osaka, Japan; 2GlaxoSmithKline, Research Triangle Park, NC, USA
|
| |
|
|
|
|
|
